2025年全球液態切片市場報告

預計未來幾年液態切片的市場規模將快速成長。到 2029 年，這一數字將成長至 27.6 億美元，複合年成長率為 17.2%。預測期內的成長將歸因於應用範圍的擴大、癌症監測、新興技術、伴隨診斷和生物標記的發現。預測期內的關鍵趨勢包括癌症檢測和監測、治療監測、微小殘留疾病 (MRD) 監測以及非癌症應用中的液態切片。

政府增加對癌症檢測進步的資助是推動液態切片市場成長的主要因素。這筆資金主要來自全球癌症負擔的增加、早期發現以改善治療效果的需求，以及透過創新診斷技術降低醫療成本的重視。政府的支持將透過加速研究、資助臨床試驗和推廣使用先進的非侵入性診斷方法進行早期癌症檢測和個人化治療方法來幫助液態切片的發展。例如，2024 年 10 月，英國政府網站 gov.UK 報告稱，已撥款 1.18 億英鎊（1.5038 億美元）用於英國的研究和創新。因此，政府對癌症檢測進步的資助增加正在推動液態切片市場的成長。

預計癌症發生率的上升將推動液態切片市場的擴張。癌症的特徵是細胞增殖不受控制且具有侵襲性，可以透過液態切片技術檢測出來。這些技術可以識別患者血液樣本中的癌症特異性生物標記物，例如循環腫瘤DNA（ctDNA）和循環性腫瘤細胞（CTC），從而實現非侵入性診斷和監測。例如，美國癌症協會預測，美國新診斷的癌症病例將從 2022 年的 1,918,030 多例增加到 2023 年的 1,958,310 例。癌症發生率的快速成長正在推動液態切片市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球液態切片PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球液態切片市場：成長率分析
• 全球液態切片市場表現：規模與成長，2019-2024
• 全球液態切片市場預測：規模與成長，2024-2029，2034
• 全球液態切片總目標市場（TAM）

第6章市場區隔

• 全球液態切片市場（依產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 檢測試劑套件
• 裝置
• 服務
• 全球液態切片市場（依臨床應用）表現及預測（2019-2024、2024-2029、2034）
• 早期癌症篩檢
• 治療方法方案
• 治療監測
• 復發監測整形外科
• 全球液態切片市場（按最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 參考實驗室
• 醫院和醫生檢查室
• 學術研究中心
• 全球液態切片市場，按檢測試劑套件類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
• cfDNA檢測
• ctDNA檢測
• 基於外泌體的檢測
• 基於RNA的檢測
• 基於蛋白質的檢測
• 全球液態切片市場，按設備類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• PCR設備
• 次世代定序（NGS）儀器
• 微陣列儀器
• 質譜儀
• 全球液態切片市場，按服務類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
• 測試服務
• 數據分析服務
• 化驗服務
• 客製化檢測開發服務

第7章 區域和國家分析

• 全球液態切片市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球液態切片市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 液態切片市場：競爭格局
• 液態切片市場：公司簡介
  • QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • Roche Diagnostics Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Guardant Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Thermo Fisher Scientific Inc.
• Menarini Silicon Biosystems
• Biocept Inc.
• Janssen Diagnostics LLC
• Trovagene Inc.
• Fraunhofer-Gesellschaft
• MDX Health SA
• Agilent Technologies Inc.
• Illumina Inc.
• Oxford Nanopore Technologies Ltd.
• Quantum Biosystems Inc.
• Menarini Silicon Biosystems Inc.
• Pathway Genomics Corporation
• Sysmex Corporation
• Janssen Global Services LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年液態切片市場：提供新機會的國家
• 2029年液態切片市場：細分領域帶來新機會
• 2029年液態切片市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

A liquid biopsy is a non-invasive and relatively painless alternative to surgical biopsies, enabling healthcare professionals to obtain valuable information about tumors through a simple blood sample. It is a diagnostic test conducted on blood to identify the presence of cancerous cells, often used for early-stage cancer detection.

The primary product types within the liquid biopsy market encompass assay kits, instruments, and services. Assay kits provide the necessary reagents and components for conducting analytical tests, which are used in various industries such as food, cereals and dietary fiber, dairy, analytical laboratories, animal feed and nutrition, biofuels, biotechnology, wine, malting and brewing, and research. Liquid biopsy has numerous clinical applications, including early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring, which are utilized by reference laboratories, hospitals and physician laboratories, and academic and research centers in the field of orthopedics and oncology, among others.

The liquid biopsy market research report is one of a series of new reports from The Business Research Company that provides liquid biopsy market statistics, including liquid biopsy industry, regional shares, competitors with a liquid biopsy market share, detailed liquid biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the liquid biopsy industry. This liquid biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liquid biopsy market size has grown rapidly in recent years. It will grow from $1.25 billion in 2024 to $1.46 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advances in cancer research, non-invasiveness, personalized medicine, regulatory approvals, early cancer detection.

The liquid biopsy market size is expected to see rapid growth in the next few years. It will grow to $2.76 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to expanding applications, cancer monitoring, emerging technologies, companion diagnostics, biomarker discovery. Major trends in the forecast period include cancer detection and monitoring, therapeutic monitoring, minimal residual disease (mrd) monitoring, liquid biopsy in non-oncological applications.

The rise in government funding for cancer detection advancements is a major factor driving the growth of the liquid biopsy market. This funding is largely due to the increasing global cancer burden, the need for early detection to improve treatment outcomes, and the emphasis on reducing healthcare costs through innovative diagnostic technologies. Government support aids liquid biopsy development by accelerating research, funding clinical trials, and promoting the use of advanced, non-invasive diagnostic methods for early cancer detection and personalized treatment approaches. For example, in October 2024, gov.UK, a UK-based government website, reported that £118 million ($150.38 million) was allocated to UK Research and Innovation, including £54 million from the government and £64 million ($81.55 million) from partners. Therefore, the rise in government funding for cancer detection advancements is propelling the growth of the liquid biopsy market.

The rising incidence of cancer is expected to drive the expansion of the liquid biopsy market. Cancer, characterized by uncontrolled cell growth and invasive tendencies, is detectable through liquid biopsy methods. These techniques identify cancer-specific biomarkers like circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in a patient's blood sample, enabling non-invasive diagnosis and monitoring. For instance, the American Cancer Society Inc. projects an increase in newly diagnosed cancer cases in the USA, from over 1,918,030 cases in 2022 to an estimated 1,958,310 cases in 2023. This surge in cancer prevalence serves as a driver for the liquid biopsy market's growth.

Businesses are rapidly adapting to new market demands and are notably prioritizing the launch of cutting-edge products within the liquid biopsy sector. This initiative aims to address the ever-increasing requirement for liquid biopsy products and services, augmenting their revenue and establishing a competitive advantage over their competitors. As an example, in June 2023, Laboratory Corporation of America Holdings, a US-based healthcare company, introduced Labcorp Plasma Focus, a liquid biopsy test engineered for identifying cancer-associated biomarkers in individuals with advanced or metastatic solid tumors. The test leverages the analysis of cell-free DNA (cfDNA) present in a patient's blood sample, constructing a detailed genomic profile of their tumor. This approach equips oncologists to refine patient healthcare management by creating personalized and precisely targeted therapy strategies.

Prominent companies involved in the liquid biopsy market are dedicating their efforts to the development of extensive liquid biopsy panels to gain a competitive edge. These extensive liquid biopsy panels serve as advanced diagnostic tools, analyzing various biomarkers within a patient's blood sample to detect and monitor a wide array of diseases, notably cancer. For instance, in June 2022, Tempus Labs Inc., a US-based technology company focused on precision medicine through artificial intelligence, announced the introduction of xF+, the most expansive liquid biopsy panel clinically available. This panel covers a broader range of genes, including single nucleotide variants, indels in all genes, and an expanded coverage of translocations, gene rearrangements, and copy number variants. Additionally, the xF+ panel evaluates blood-based tumor mutational burden (bTMB) and microsatellite instability, providing essential predictive biomarkers for various cancer immunotherapies' efficacy.

In February 2024, Veracyte Inc., a US-based diagnostics company, acquired C2i Genomics Inc. for $70 million. Through this acquisition, Veracyte aims to enhance its diagnostics platform by integrating whole-genome minimal residual disease (MRD) capabilities. This deal allows Veracyte to leverage C2i's AI-driven technology to improve the detection of circulating tumor DNA from blood samples, with the goal of expanding its cancer care offerings. C2i Genomics Inc., also based in the US, specializes in AI-powered liquid biopsy for cancer diagnostics.

Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE PLC, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.

North America was the largest region in the liquid biopsy market in 2024. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the liquid biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The liquid biopsy market includes revenues earned by entities by DNA collection tubes, tests, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liquid Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liquid biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liquid biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liquid biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Assays Kits; Instruments; Services
• 2) By Clinical Application: Early Cancer Screening; Therapy Selection; Treatment Monitoring; Recurrence Monitoring Orthopedics
• 3) By End User: Reference Laboratories; Hospitals and Physician Laboratories; Academic and Research Centers
• Subsegments:
• 1) By Assays Kits: cfDNA Assays; ctDNA Assays; Exosome-based Assays; RNA-based Assays; Protein-based Assays
• 2) By Instruments: PCR Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; Mass Spectrometry Instruments
• 3) By Services: Testing Services; Data Analysis Services; Laboratory Services; Custom Assay Development Services
• Companies Mentioned: QIAGEN NV; Roche Diagnostics Ltd.; Bio-Rad Laboratories Inc.; Myriad Genetics Inc.; Guardant Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liquid Biopsy Market Characteristics

3. Liquid Biopsy Market Trends And Strategies

4. Liquid Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Liquid Biopsy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Liquid Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Liquid Biopsy Market Growth Rate Analysis
• 5.4. Global Liquid Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Liquid Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Liquid Biopsy Total Addressable Market (TAM)

6. Liquid Biopsy Market Segmentation

• 6.1. Global Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Assays Kits
• Instruments
• Services
• 6.2. Global Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring Orthopedics
• 6.3. Global Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reference Laboratories
• Hospitals and Physician Laboratories
• Academic and Research Centers
• 6.4. Global Liquid Biopsy Market, Sub-Segmentation Of Assays Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• cfDNA Assays
• ctDNA Assays
• Exosome-based Assays
• RNA-based Assays
• Protein-based Assays
• 6.5. Global Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Instruments
• Next-Generation Sequencing (NGS) Instruments
• Microarray Instruments
• Mass Spectrometry Instruments
• 6.6. Global Liquid Biopsy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Testing Services
• Data Analysis Services
• Laboratory Services
• Custom Assay Development Services

7. Liquid Biopsy Market Regional And Country Analysis

• 7.1. Global Liquid Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Liquid Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liquid Biopsy Market

• 8.1. Asia-Pacific Liquid Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liquid Biopsy Market

• 9.1. China Liquid Biopsy Market Overview
• 9.2. China Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liquid Biopsy Market

• 10.1. India Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liquid Biopsy Market

• 11.1. Japan Liquid Biopsy Market Overview
• 11.2. Japan Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liquid Biopsy Market

• 12.1. Australia Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liquid Biopsy Market

• 13.1. Indonesia Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liquid Biopsy Market

• 14.1. South Korea Liquid Biopsy Market Overview
• 14.2. South Korea Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liquid Biopsy Market

• 15.1. Western Europe Liquid Biopsy Market Overview
• 15.2. Western Europe Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liquid Biopsy Market

• 16.1. UK Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liquid Biopsy Market

• 17.1. Germany Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liquid Biopsy Market

• 18.1. France Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liquid Biopsy Market

• 19.1. Italy Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liquid Biopsy Market

• 20.1. Spain Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liquid Biopsy Market

• 21.1. Eastern Europe Liquid Biopsy Market Overview
• 21.2. Eastern Europe Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liquid Biopsy Market

• 22.1. Russia Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liquid Biopsy Market

• 23.1. North America Liquid Biopsy Market Overview
• 23.2. North America Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liquid Biopsy Market

• 24.1. USA Liquid Biopsy Market Overview
• 24.2. USA Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liquid Biopsy Market

• 25.1. Canada Liquid Biopsy Market Overview
• 25.2. Canada Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liquid Biopsy Market

• 26.1. South America Liquid Biopsy Market Overview
• 26.2. South America Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liquid Biopsy Market

• 27.1. Brazil Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liquid Biopsy Market

• 28.1. Middle East Liquid Biopsy Market Overview
• 28.2. Middle East Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liquid Biopsy Market

• 29.1. Africa Liquid Biopsy Market Overview
• 29.2. Africa Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liquid Biopsy Market Competitive Landscape And Company Profiles

• 30.1. Liquid Biopsy Market Competitive Landscape
• 30.2. Liquid Biopsy Market Company Profiles
  • 30.2.1. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Diagnostics Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Guardant Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Liquid Biopsy Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Menarini Silicon Biosystems
• 31.3. Biocept Inc.
• 31.4. Janssen Diagnostics LLC
• 31.5. Trovagene Inc.
• 31.6. Fraunhofer-Gesellschaft
• 31.7. MDX Health SA
• 31.8. Agilent Technologies Inc.
• 31.9. Illumina Inc.
• 31.10. Oxford Nanopore Technologies Ltd.
• 31.11. Quantum Biosystems Inc.
• 31.12. Menarini Silicon Biosystems Inc.
• 31.13. Pathway Genomics Corporation
• 31.14. Sysmex Corporation
• 31.15. Janssen Global Services LLC

32. Global Liquid Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liquid Biopsy Market

34. Recent Developments In The Liquid Biopsy Market

35. Liquid Biopsy Market High Potential Countries, Segments and Strategies

• 35.1 Liquid Biopsy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Liquid Biopsy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Liquid Biopsy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer